Evidence map›Paper›PMID 41309521›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026

Polystyrene Microplastics Exposure Aggravates Clear Cell Renal Cell Carcinoma Progression via the NF-κB and TGF-β Signaling Pathways.

Shiqi Ye, Jianfeng Xiang, Siqi Zhou, Qintao Ge, Aihetaimujiang Anwaier, Kun Chang, Gang Wei, Jiahe Lu, Xi Tian, Shuxuan Zhu and 9 more

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Shiqi YeDepartment of Urology, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Shanghai Genitourinary Cancer Institute, Fudan University, Shanghai, 200032, China.ORCID https://orcid.org/0009-0007-9070-443X
Jianfeng XiangDepartment of Interventional Oncology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200127, China.
Siqi ZhouDepartment of Urology, Huadong Hospital, Fudan University, Shanghai, 200040, China.
Qintao GeDepartment of Urology, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Shanghai Genitourinary Cancer Institute, Fudan University, Shanghai, 200032, China.
Aihetaimujiang AnwaierDepartment of Urology, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Shanghai Genitourinary Cancer Institute, Fudan University, Shanghai, 200032, China.
Kun ChangDepartment of Urology, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Shanghai Genitourinary Cancer Institute, Fudan University, Shanghai, 200032, China.
Gang WeiBeijing Key Laboratory of Diabetes Research and Care, Department of Endocrinology, Beijing Diabetes Institute, Beijing Tongren Hospital, Capital Medical University, Beijing, 100730, China.
Jiahe LuDepartment of Urology, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Shanghai Genitourinary Cancer Institute, Fudan University, Shanghai, 200032, China.
Xi TianDepartment of Urology, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Shanghai Genitourinary Cancer Institute, Fudan University, Shanghai, 200032, China.
Shuxuan ZhuDepartment of Urology, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Shanghai Genitourinary Cancer Institute, Fudan University, Shanghai, 200032, China.
Yuchen JiangDepartment of Urology, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Shanghai Genitourinary Cancer Institute, Fudan University, Shanghai, 200032, China.
Wei ZhangDepartment of Urology, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Shanghai Genitourinary Cancer Institute, Fudan University, Shanghai, 200032, China.
Tingting CaiDepartment of Urology, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Shanghai Genitourinary Cancer Institute, Fudan University, Shanghai, 200032, China.
Moran XuDepartment of Urology, Huadong Hospital, Fudan University, Shanghai, 200040, China.
Dingwei YeDepartment of Urology, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Shanghai Genitourinary Cancer Institute, Fudan University, Shanghai, 200032, China.
Danfeng XuDepartment of Urology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
Tao WangDepartment of Interventional Oncology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200127, China.
Hailiang ZhangDepartment of Urology, Huadong Hospital, Fudan University, Shanghai, 200040, China.
Wenhao XuDepartment of Urology, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Shanghai Genitourinary Cancer Institute, Fudan University, Shanghai, 200032, China.ORCID https://orcid.org/0000-0002-0660-9162

Funding

Joint Breakthrough Project for New Frontier Technologies of the Shanghai Hospital Development Center SHDC12022105National Natural Science Foundation of China 82 403 377National Natural Science Foundation of China 82 473 192National Natural Science Foundation of Shanghai 25ZR1401067Noncommunicable Chronic Diseases-National Science and Technology Major Project 2023ZD0510300Scientific Innovation Project of Shanghai Education Committee 2021-01-07-00-07-E00080Shanghai Anticancer Association EYAS project SACA-CY23A02Shanghai Anticancer Association EYAS project SACA-CY23C04
6 · The paper itself

Abstract

Polystyrene microplastics (PS-MPs) are increasingly associated with carcinogenesis. However, their specific role in clear cell renal cell carcinoma (ccRCC) remains unclear. In this study, the microplastics in ccRCC tissues and normal adjacent tissues (NAT) are detected utilizing Py-GC/MS, LDIR, and SEM. Tumor functional assays are conducted to assess the effects of PS-MPs on ccRCC cellular behaviors. Transcriptomic alterations induced by PS-MPs are characterized via RNA-sequencing (RNA-seq) analysis. Key signaling pathways are investigated through immunoblotting, immunocytochemistry, and ELISA. PDO and CDX models are employed to evaluate the effects of PS-MPs on ccRCC progression and intervention strategies. The results demonstrate that PS-MPs are markedly abundant in ccRCC tissues compared to NAT. Cytoplasmic accumulation of PS-MPs promotes malignant phenotypes in ccRCC cells. RNA-seq analysis demonstrates significant enrichment of oncogenic pathways following PS-MPs exposure. Mechanistic validation confirms PS-MPs exposure activates the NF-κB and TGF-β pathways in ccRCC. In preclinical models, PS-MPs accelerate ccRCC growth, which is attenuated by treatment with the pathway inhibitors. In conclusion, this study provides the first comprehensive evidence that PS-MPs exacerbate ccRCC progression through activating the NF-κB and TGF-β pathways. These findings establish PS-MPs as an environmental risk factor for ccRCC and identify potential therapeutic targets to counteract PS-MPs-mediated oncogenic effects.

Indexed as

Carcinoma, Renal CellKidney NeoplasmsMicroplasticsNF-kappa BPolystyrenesSignal TransductionTransforming Growth Factor betaAnimalsCell Line, TumorDisease ProgressionHumansMiceMicroplasticsNF-kappa BPolystyrenesTransforming Growth Factor betaclear cell renal cell carcinoma (ccRCC)epithelial‐mesenchymal transition (EMT)nuclear factor‐kappa B (NF‐κB)polystyrene microplastics (PS‐MPs)transforming growth factor‐beta (TGF‐β)

Identifiers

PMID41309521
PMCPMC12884784

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.